Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.
Norah A TerraultJames BurtonMark GhobrialElizabeth VernaJohanna BayerChristina KleinDavid VictorSumit MohanJames TrotterJennifer DodgeClaus U NiemannRaymond A RubinPublished in: Hepatology (Baltimore, Md.) (2021)
Despite differing kinetics of early HCV infection in liver versus non-liver recipients, a preemptive antiviral strategy is effective. Vigilance for adverse immunologic events is warranted.
Keyphrases